Advanced Medicine

Engineered cell therapies hold exciting potential for the pharmaceutical industry – but only if contract manufacturing organizations and vendors play their part in the revolution.

We live in exciting times for the biopharma industry.

A new personalized test aims to predict which side effects a patient will suffer from.

The UK aims high with a new manufacturing center designed to meet the needs of cell and gene therapies.

Precision medicine holds much promise; are companies up to the challenge?

Personalized cell-based therapies have been hyped as the future of medicine, but are current manufacturing technologies up to the task?

DNA vaccine helps turn patients’ own cells into antibody-producing factories.

Personalized medicine looks set to transform the biopharma landscape, and will demand significant changes in production methods.

How much do the public really know about pharma R&D?

Can nanotechnology pick up where personalized medicine leaves off?